Donors
Cancer immunotherapy is a tumor-agnostic approach and can be used to treat patients with different types of solid and hematological malignancies. Thus, our lab works on various malignancies including melanoma, renal cell carcinoma, lung cancer, prostate cancer, breast cancer, pancreatic cancer, head and neck cancer, and childhood cancers. We use novel treatments such as microbiome modification strategies to improve patient’s response to immunotherapy.
Our research brings these novel cancer treatments to patients in London and other parts of Canada through phase I clinical trials. Various projects in our lab are funded directly by philanthropic donations to our lab. For more information on how you can donate to our research and help bring new treatments to cancer patients, please contact us.
On March 23, 2023 London Health Sciences Foundation (LHSF) is proud to announce a $1 million gift from Andy and Helen Spriet in support of establishing an immuno-oncology research program at London Health Sciences Centre’s (LHSC) London Regional Cancer Program (LRCP). With this transformative gift, the Spriet’s have propelled Dr. Saman Maleki and London onto the world stage for rare fecal microbiota transplantation (FMT) in combination with immunotherapy, revolutionizing cancer treatment options in an unconventional way.
